Seon-Jeong Kim
Financieel Directeur/CFO bij MEDPACTO, INC.
Vermogen: 228 446 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Seon-Jeong Kim
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Seon-Jeong Kim via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Georgia Institute of Technology | College/University | Doctorate Degree | |
| University of Iowa | College/University | Doctorate Degree | |
| Yonsei University | College/University | Doctorate Degree | |
| Seoul National University | College/University | Corporate Officer/Principal | |
| Kyoto University | College/University | Doctorate Degree | |
| University of Tsukuba | College/University | Doctorate Degree | |
| THERAGEN ETEX CO.,LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CHA University | College/University | Corporate Officer/Principal | |
| RUSSELL CO., LTD. | Industrial Machinery | Comptroller/Controller/Auditor | |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Biotechnology | Founder |
Statistieken
Internationaal
| Zuid-Korea | 6 |
| Verenigde Staten | 4 |
| Japan | 3 |
Sectoraal
| Consumer Services | 8 |
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Operationeel
| Director/Board Member | 5 |
| Doctorate Degree | 5 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Seong-Jin Kim | 5 |
| Young-Shik Kim | 3 |
| Byung-Ho Lee | 3 |
| Jeong-Im Heo | 2 |
| Gi-Baek Ham | 2 |
- Beurs
- Insiders
- Seon-Jeong Kim
- Bedrijfsconnecties
